IMMX — IMMIX BIOPHARMA INC
As of Q2 2026, 26 SEC-registered investment managers reported holding IMMX (IMMIX BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $159.53M across 17.21M shares. That is +53.6% by share count (+6.00M shares) versus the previous quarter, while reported value moved +62.3%. Ownership is concentrated: the five largest holders account for 66.4% of reported value and the top ten for 89.3%.
Compared with the prior quarter, 9 opened new positions, 16 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
IMMX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 4.80M | $43.70M | 0.02% | Add |
| BlackRock Inc history | Q2 2026 | 2.99M | $30.83M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 2.07M | $21.30M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 1.94M | $20.02M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 1.79M | $18.51M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.47M | $15.19M | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 1.20M | $12.39M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 969.12K | $9.99M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 1.10M | $5.73M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 537.76K | $5.54M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 418.05K | $4.31M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 417.23K | $4.30M | 0.01% | New |
| Bank of America Corp history | Q2 2026 | 413.14K | $4.26M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 235.72K | $2.43M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 174.11K | $1.80M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 159.47K | $1.64M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 146.85K | $1.51M | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 258.60K | $1.35M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 127.26K | $1.31M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 113.32K | $1.17M | 0.00% | Add |
New Positions (Q2 2026)
- Wellington Management Group 1.47M sh · $15.19M
- Balyasny Asset Management 417.23K sh · $4.30M
- D. E. Shaw & Co 93.11K sh · $959.92K
- Deutsche Bank AG 40.86K sh · $421.28K
- Two Sigma Investments 40.18K sh · $414.27K
- Invesco Ltd 22.32K sh · $230.10K
- JPMorgan Chase & Co 19.57K sh · $205.34K
- Legal & General Investment Management America 3.98K sh · $41.09K
- Fidelity Management & Research (FMR) 61 sh · $629
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 4.80M sh · $43.70M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | 14.00K | 14.08K | 11.82K | 40.30K | 43.07K | 130.25K | 468.38K | 2.99M |
| Millennium Management | 20.47K | — | — | — | — | — | — | — | — | 54.28K | 26.30K | 21.52K | — | — | — | — | 1.66M | 1.75M | 2.07M |
| UBS Group AG | 32.65K | — | 4.34K | 12.00K | 4.69K | 2.30K | — | — | 2.63K | 5.26K | 3.15K | 6.15K | 14.21K | 10.12K | 13.97K | 1.94K | 58.60K | 76.83K | 1.94M |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 55.03K | 1.98M | 1.64M | 1.79M |
| Wellington Management Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.47M |
| Geode Capital Management | — | — | 73.33K | 76.77K | 76.54K | 79.72K | 60.33K | 73.02K | 83.43K | 124.77K | 142.13K | 150.08K | 150.08K | 160.74K | 161.12K | 187.48K | 246.06K | 463.38K | 1.20M |
| Franklin Resources | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 980.39K | 969.07K | 969.12K |
| Citadel Advisors | 26.47K | 21.71K | — | — | — | — | — | — | — | — | — | 10.10K | 12.40K | — | — | 89.80K | 75.34K | 47.17K | 537.76K |
| Northern Trust Corp | — | — | — | 19.15K | 19.15K | — | — | — | 24.38K | 38.91K | 38.91K | 38.91K | 38.91K | 95.26K | 93.89K | 89.30K | 100.66K | 138.23K | 418.05K |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 12.85K | — | 417.23K |
| Bank of America Corp | — | — | — | — | 10 | — | — | — | 1.59K | — | 115 | 115 | 114 | 120 | 139 | 12 | 16 | 41.13K | 413.14K |
| BNY Mellon | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 98.73K | 83.61K | 235.72K |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 208.37K | 95.40K | 174.11K |
| Morgan Stanley | — | — | — | 3 | 1 | — | — | 400 | 16.17K | 54.05K | 58.46K | 84.31K | 91.05K | 82.29K | 124.92K | 120.67K | 126.62K | 139.89K | 159.47K |
| Manulife Financial | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 28.96K | 146.85K |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 27.46K | 127.26K |
| Wells Fargo & Co | — | 26 | 70 | 36 | 37 | 38 | 42 | 57 | 391 | 434 | 330 | 330 | 330 | 330 | 330 | 330 | — | 17.15K | 113.32K |
| D. E. Shaw & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 93.11K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 35 | 1.97K | 2.46K | 70.65K |
| Deutsche Bank AG | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 40.86K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details